Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Publication Details

Modelling hepatitis C transmission over a social network of injecting drug users

Rolls DA, Daraganova G, Sacks-Davis R, Hellard M, Jenkinson R, McBryde E, Pattison PE, Robins GL

(2012), J Theor Biol, 297, 73-87

Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia

Peel T, Cheng AC, Spelman T, Huysmans M, Spelman D

(2012), Clin Microbiol Infect, 18(4), 388-94

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection

Grebely J, Pham ST, Matthews GV, Petoumenos K, Bull RA, Yeung B, Rawlinson W, Kaldor J, Lloyd A, Hellard M, Dore GJ, White PA; ATAHC Study Group

(2012), Hepatology, 55(4), 1058-69

Know your limits: awareness of the 2009 Australian alcohol guidelines among young people

Bowring AL, Gold J, Dietze P, Gouillou M, van Gemert C, Hellard ME

(2012), Drug Alcohol Rev, 31(2), 213-23

HIV and age do not substantially interact in HIV-associated neurocognitive impairment

Cysique LA, Maruff P, Bain MP, Wright E, Brew BJ

(2011), J Neuropsychiatry Clin Neurosci, 23(1), 83-9

Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis

Arenas-Pinto A, Grant A, Bhaskaran K, Copas A, Carr A, Worm SW, Martinez E, Reiss P, Dunn D, Weber R, Hoy J, Weller I; Lactic Acidosis International Study Group

(2011), Antivir Ther, 16(2), 219-26

Bone, fracture and frailty

Hoy J

(2011), Curr Opin HIV AIDS, 6(4), 309-14

Comment on: The DART Trial: 'The Doctor's Dilemma' revisited

Woolley I, Kanapathipillai R

(2011), J Antimicrob Chemother, 66(9), 2192-3

The clinical significance of CD4 counts in Asian and caucasian HIV-infected populations: results from TAHOD and AHOD

Achhra AC, Zhou J, Choi JY, Hoy J, Zhang F, Templeton DJ, Merati T, Woolley I, Petoumenos K, Amin J; TAHOD and AHOD

(2011), J Int Assoc Physicians AIDS Care, 10(3), 160-70

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients

Duprez DA, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD; INSIGHT SMART Group

(2011), AIDS, 25(5), 651-7

Trends in detectable viral load by calendar year in the Australian HIV observational database

Law MG, Woolley I, Templeton DJ, Roth N, Chuah J, Mulhall B, Canavan P, McManus H, Cooper DA, Petoumenos K; Australian HIV Observational Database (AHOD)

(2011), J Int AIDS Soc, 14, 10

Triple class experience after initiation of combination antiretroviral treatment in Australia: survival and projections

Pour SM, Woolley I, Canavan P, Chuah J, Russell DB, Law M, Petoumenos K

(2011), Sex Health, 8(3), 295-303

Systemic absorption from oral vancomycin: check the dose!

Coutsevelis J, Witney K, Corallo CE, Spelman D

(2011), J Pharm Pract Res, 41(3), 225-6

Mumps presenting as epididymo-orchitis among young travellers: under-recognition, missed diagnoses and transmission risks

Doyle JS, Paige EK, Spelman DW

(2011), Med J Aust, 194(6), 317-8

Insights into Acinetobacter baumannii pathogenicity

Cerqueira GM, Peleg AY

(2011), IUBMB Life, 63(12), 1055-60

The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes

Cameron DR, Howden BP, Peleg AY

(2011), Clin Infect Dis, 53(6), 576-82

Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections

Qureshi ZA, Paterson DL, Pakstis DL, Adams-Haduch JM, Sandkovsky G, Sordillo E, Polsky B, Peleg AY, Bhussar MK, Doi Y

(2011), Int J Antimicrob Agents, 37(1), 26-32

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis

Neoh CF, Liew D, Slavin M, Marriott D, Chen SC, Morrissey O, Stewart K, Kong DC

(2011), J Antimicrob Chemother, 66(8), 1906-15

An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009

Lingaratnam S, Slavin MA, Mileshkin L, Solomon B, Burbury K, Seymour JF, Sharma R, Koczwara B, Kirsa SW, Davis ID, Prince M, Szer J, Underhill C, Morrissey O, Thursky KA

(2011), Intern Med J, 41(1b), 110-20

Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee

Lingaratnam S, Slavin MA, Koczwara B, Seymour JF, Szer J, Underhill C, Prince M, Mileshkin L, O'Reilly M, Kirsa SW, Bennett CA, Davis ID, Morrissey O, Thursky KA; Australian Consensus Guidelines 2011 Steering Committee

(2011), Intern Med J, 41(1b), 75-81